bisphosphonates update by alison dougal
DESCRIPTION
TRANSCRIPT
![Page 1: Bisphosphonates Update by Alison Dougal](https://reader034.vdocument.in/reader034/viewer/2022050920/549cf322ac7959a62a8b4804/html5/thumbnails/1.jpg)
Dr Alison DougallConsultant for Medically Compromised Patients
Dublin Dental School and Hospital
Bis-phosphonates update
![Page 2: Bisphosphonates Update by Alison Dougal](https://reader034.vdocument.in/reader034/viewer/2022050920/549cf322ac7959a62a8b4804/html5/thumbnails/2.jpg)
• Fear• Confusion• Uncertainty• Risk• Panic• Warning• Litigation
![Page 3: Bisphosphonates Update by Alison Dougal](https://reader034.vdocument.in/reader034/viewer/2022050920/549cf322ac7959a62a8b4804/html5/thumbnails/3.jpg)
PATIENT WARNING : avoid invasive dentistry!!!
![Page 4: Bisphosphonates Update by Alison Dougal](https://reader034.vdocument.in/reader034/viewer/2022050920/549cf322ac7959a62a8b4804/html5/thumbnails/4.jpg)
Jump into unknown = TroubleFear = Neglect
How much do we need to know?
![Page 5: Bisphosphonates Update by Alison Dougal](https://reader034.vdocument.in/reader034/viewer/2022050920/549cf322ac7959a62a8b4804/html5/thumbnails/5.jpg)
1st Generation – oral bisphosphonates
• Introduced in 1990’s• Improve bone quality in
Pagets Disease• Osteoporosis
– Alternative to HRT in post menopause women
– Prevent fractures of spine, wrist and hip
– 2ndry to corticosteroid use, SLE, RA,
• Injectables introduced for pts with dosing difficulties, inability to sit upright for 60 mins or swallow tablets
![Page 6: Bisphosphonates Update by Alison Dougal](https://reader034.vdocument.in/reader034/viewer/2022050920/549cf322ac7959a62a8b4804/html5/thumbnails/6.jpg)
2nd and 3rd Generation – IV bisphosphonates
• Hypercalcaemia of malignancy
• Prevent metastatic tumours in breast, lung and prostate cancer
• Prevent bone complications and pain in multiple myeloma and kidney disease
• Prevent post-operative fractures and weakness in kidney, liver and cardiac transplant patients
![Page 7: Bisphosphonates Update by Alison Dougal](https://reader034.vdocument.in/reader034/viewer/2022050920/549cf322ac7959a62a8b4804/html5/thumbnails/7.jpg)
Wonder Drug?• 19th most prescribed drug group
worldwide• Synthetic analogues of
pyrophosphates• Not metabolised• ½ absorbed dose is distributed to
bone• Increase bone density and thickness• Prevent tumours from removing bone
and spreading– Inhibit differentiation of bone marrow
cells into osteoclasts– Inhibit Osteoclast activity– Reduction in bone turnover and
resorption– Reduce local release of factors that
stimulate tumour growth
![Page 8: Bisphosphonates Update by Alison Dougal](https://reader034.vdocument.in/reader034/viewer/2022050920/549cf322ac7959a62a8b4804/html5/thumbnails/8.jpg)
Side effects • Osteoclast function severely impaired
• Osteocytes not repaced• Capillary network in
bone not maintained• Bone becomes too
dense choking capillary network
• Avascular bone necrosis
• Osteonecrosis• Osteochemonecrosis• BON, ONJ
![Page 9: Bisphosphonates Update by Alison Dougal](https://reader034.vdocument.in/reader034/viewer/2022050920/549cf322ac7959a62a8b4804/html5/thumbnails/9.jpg)
Incidence of ONJ in maxilla and mandible
• 3000 world cases– (191 million prescriptions)
• Mostly associated with intra-venous bis-phosphonates – Zometa (Zoledronic Acid)– Aredia (Palmidronate)
• Mostly following dental extractions or periodontal surgery
• Some spontaneously– Chronic infection– Trauma
![Page 10: Bisphosphonates Update by Alison Dougal](https://reader034.vdocument.in/reader034/viewer/2022050920/549cf322ac7959a62a8b4804/html5/thumbnails/10.jpg)
Risk factors
• IV Bisphosphonate = higher risk for BON– 50% of dose is bio available for bone matrix
• Oral bis-phosphonate = low risk for BON– 1% dose of is absorbed by GI Tract
• Recent assessment test for necrosis potential– Arun Garg/Marx - Miami– C-Terminal Telopeptide (CTX) -– marker for serum
bone turnover– scores - controversial
• Time– Half life is 8-10 years
![Page 11: Bisphosphonates Update by Alison Dougal](https://reader034.vdocument.in/reader034/viewer/2022050920/549cf322ac7959a62a8b4804/html5/thumbnails/11.jpg)
Co-risk problems– Immune-suppression
• Diabetes• HIV• Leukaemia• Transplants
– Drug Therapy • Corticosteroids• Chemo-therapy• Immune suppressants
– Age – SLE, RA & auto-immune
diseases – Clotting Disorders– Sickle cell Disease
![Page 12: Bisphosphonates Update by Alison Dougal](https://reader034.vdocument.in/reader034/viewer/2022050920/549cf322ac7959a62a8b4804/html5/thumbnails/12.jpg)
Why a dental problem?
• Bis Ph. accumulate in high turnover areas
• Higher concentrations of drug in mandible than elsewhere
• After trauma or infection bone cannot respond adequately
• Masticatory Forces– Chronic Low Grade Trauma– Unable to repair micro-fractures
• Necrotic Bone• Bony sequestrum
![Page 13: Bisphosphonates Update by Alison Dougal](https://reader034.vdocument.in/reader034/viewer/2022050920/549cf322ac7959a62a8b4804/html5/thumbnails/13.jpg)
Clinical Presentation
• Delayed or absent healing after extractions• Ragged Ulceration with bony base• Exposed or denuded bone
– May be symptomless unless 2ndry infection
• Mobile Teeth – may mimic periodontal disease• Bone Pain
– Chronic Pain– Heavy Jaw– Numbness
• Ref. to oral medicine clinic/Max Fax
![Page 14: Bisphosphonates Update by Alison Dougal](https://reader034.vdocument.in/reader034/viewer/2022050920/549cf322ac7959a62a8b4804/html5/thumbnails/14.jpg)
Spontaneous necrosis in periodontal disease
![Page 15: Bisphosphonates Update by Alison Dougal](https://reader034.vdocument.in/reader034/viewer/2022050920/549cf322ac7959a62a8b4804/html5/thumbnails/15.jpg)
Trauma from denture flange
![Page 16: Bisphosphonates Update by Alison Dougal](https://reader034.vdocument.in/reader034/viewer/2022050920/549cf322ac7959a62a8b4804/html5/thumbnails/16.jpg)
Denuded mandibular torus
![Page 17: Bisphosphonates Update by Alison Dougal](https://reader034.vdocument.in/reader034/viewer/2022050920/549cf322ac7959a62a8b4804/html5/thumbnails/17.jpg)
Presenting Complaint ulceration >3 months
![Page 18: Bisphosphonates Update by Alison Dougal](https://reader034.vdocument.in/reader034/viewer/2022050920/549cf322ac7959a62a8b4804/html5/thumbnails/18.jpg)
Following extraction
![Page 19: Bisphosphonates Update by Alison Dougal](https://reader034.vdocument.in/reader034/viewer/2022050920/549cf322ac7959a62a8b4804/html5/thumbnails/19.jpg)
![Page 20: Bisphosphonates Update by Alison Dougal](https://reader034.vdocument.in/reader034/viewer/2022050920/549cf322ac7959a62a8b4804/html5/thumbnails/20.jpg)
![Page 21: Bisphosphonates Update by Alison Dougal](https://reader034.vdocument.in/reader034/viewer/2022050920/549cf322ac7959a62a8b4804/html5/thumbnails/21.jpg)
Treatment• Clinical Management based on expert
opinion• No evidence base yet• Most post op treatment not effective
– Antibiotics– Withdrawing bis-phosphonate therapy– Hyperbaric oxygen– Surgical resection of necrotic bone
• Prevention is best option• Dental screening before patient commences
drug therapy
![Page 22: Bisphosphonates Update by Alison Dougal](https://reader034.vdocument.in/reader034/viewer/2022050920/549cf322ac7959a62a8b4804/html5/thumbnails/22.jpg)
www.education!!!
• Education– Patient http://
www.ada.org/public/topics/osteonecrosis.asp– Dental Team
www.jada.ada.org– Oncologists/Medical Profession
www.jopasco.org Practical Guidelines for treatment of
osteonecrosis in patients with cancer. Journal of Oncology Practice 2006 Vol 2 Issue 1
![Page 23: Bisphosphonates Update by Alison Dougal](https://reader034.vdocument.in/reader034/viewer/2022050920/549cf322ac7959a62a8b4804/html5/thumbnails/23.jpg)
Practice Points
![Page 24: Bisphosphonates Update by Alison Dougal](https://reader034.vdocument.in/reader034/viewer/2022050920/549cf322ac7959a62a8b4804/html5/thumbnails/24.jpg)
Special Care Patients• Medical History
– Likely Pt groups • Post menopausal women• Patients with history of hip fractures• Osteoporosis• Pagets Disease• Breast cancer• Prostate Cancer• Lung Cancer• Multiple myeloma• Transplant Patients• Kidney Failure/Dialysis
![Page 25: Bisphosphonates Update by Alison Dougal](https://reader034.vdocument.in/reader034/viewer/2022050920/549cf322ac7959a62a8b4804/html5/thumbnails/25.jpg)
Drug History/Route
• Oral Bisphosphonates – daily tablets– Actonel (Risendronate)– Boniva (Ibandronate)– Didronel (Etidronate)– Fossamax (alendronate) – Skelid (Tiludronate)
• IV Bisphosphonates – monthly injections– Zometa® (Zoledronate)– Aredia®) (Pamidronate) – Bonefos®/Loron® (Clodronate)
• Important to know how long drug has been taken
![Page 26: Bisphosphonates Update by Alison Dougal](https://reader034.vdocument.in/reader034/viewer/2022050920/549cf322ac7959a62a8b4804/html5/thumbnails/26.jpg)
Fossamax
• 13th most prescribed drug in the world
• 170 cases BON worldwide (since 2006)
• No true cause-effect relationship• Extremely Low Risk BON• 0.7 cases per 100,000 person years
exposure
![Page 27: Bisphosphonates Update by Alison Dougal](https://reader034.vdocument.in/reader034/viewer/2022050920/549cf322ac7959a62a8b4804/html5/thumbnails/27.jpg)
Dental management of patients receiving oral bisphosphonate therapy
• www.ada.org/prof/resources/topics/osteonecrosis.asp• Dentist should inform pt that low risk of developing
BON• Ways to minimise risk but not eliminate it• Good oral hygiene with regular dental care is best way
to lower the risk • Patients shown how to screen their mouths for signs • Routine dental treatment should not be modified• Alternatives to extractions should be offered • Non surgical periodontal management preferred• Care with fit of dentures
![Page 28: Bisphosphonates Update by Alison Dougal](https://reader034.vdocument.in/reader034/viewer/2022050920/549cf322ac7959a62a8b4804/html5/thumbnails/28.jpg)
Fossamax – 8 years
![Page 29: Bisphosphonates Update by Alison Dougal](https://reader034.vdocument.in/reader034/viewer/2022050920/549cf322ac7959a62a8b4804/html5/thumbnails/29.jpg)
Oral Surgery/Perio surgery
• Do not stop bis-phosphonate therapy• Informed Consent Form
– ADA website has template• Chlorhexidine rinse pre-op• Limit extraction or perio surgery to one sextant• Suture to prevent soft tissue trauma• Avoid packing – surgicell etc• Irrigation of socket with chlorhexidine post-op• No further surgery for two months to assess healing• Care with trauma from immediate dentures/splints• Post-op antibiotics only if co-risk factors
– Metronidazole 200mg tds for five days– Amoxycillin 500mg TDS for fourteen days– Or clinadamycin 300mg TDS for fourteen days
![Page 30: Bisphosphonates Update by Alison Dougal](https://reader034.vdocument.in/reader034/viewer/2022050920/549cf322ac7959a62a8b4804/html5/thumbnails/30.jpg)
Aids to prevention• Inform patient of the consequences of oral
neglect• Xerostomia• Professionally applied products
– Cervitec• 1% Chlorhexidine• 1% thymol
• Home applied products– GC Tooth mousse
• Water Soluble mousse• Buffer which neutralises acidic saliva• Recaldent (Amorphous Calcium Phosphate)• Aids remineralisation• Applied with finger once per day
![Page 31: Bisphosphonates Update by Alison Dougal](https://reader034.vdocument.in/reader034/viewer/2022050920/549cf322ac7959a62a8b4804/html5/thumbnails/31.jpg)
• Patients at higher risk of developing BON • Routine care as per oral bisphosphonate therapy• Tori – high risk area for trauma• Regular hygienist input encouraged but care with
mechanical intrumentation• Accidental trauma – recommend soft
toothbrush/changed often• Avoid extractions and periodontal surgery if at all
possible• Implants contra-indicated• Endodontics encouraged
Dental management of patients receiving iv bisphosphonate therapy
![Page 32: Bisphosphonates Update by Alison Dougal](https://reader034.vdocument.in/reader034/viewer/2022050920/549cf322ac7959a62a8b4804/html5/thumbnails/32.jpg)
– risk of developing BON higher with time– risk of developing spontaneous BON
higher in presence of infection– risk of developing spontaneous BON
higher in presence of periodontal disease (grade 3 mobile)
– Risk greatest in mandible– Risk of developing BON higher with co-
factors
Risk assess surgery each case
![Page 33: Bisphosphonates Update by Alison Dougal](https://reader034.vdocument.in/reader034/viewer/2022050920/549cf322ac7959a62a8b4804/html5/thumbnails/33.jpg)
Guidance for practitioners• Expert Panel JADA August 2006• No data from Clinical trials• Strict regime of post-op antimicrobials
and antibiotics (anecdotal)– To prevent secondary infection
• No withdrawing of drug pre-operatively unless specified locally
• Maximum 1-2 teeth extracted in one visit• Wait 2 months before repeat surgery
![Page 34: Bisphosphonates Update by Alison Dougal](https://reader034.vdocument.in/reader034/viewer/2022050920/549cf322ac7959a62a8b4804/html5/thumbnails/34.jpg)
Dr Doctor • Liase with oncologist
– Information about the need for surgery• risks of providing and not providing care• Regime that you plan to use pre/peri and post op• Whether oncolgist would prefer to reduce/withdraw
drug pre or post operatively• FBC – check platelets
• Consent– Patients informed of risks involved with providing
and not providing treatment– Be honest –it is a gamble until the research is in
place– Involve the patient in the decisions.– Patient takes some responsibility for their dental
problem
![Page 35: Bisphosphonates Update by Alison Dougal](https://reader034.vdocument.in/reader034/viewer/2022050920/549cf322ac7959a62a8b4804/html5/thumbnails/35.jpg)
Zometa 3 months – post ca breast
![Page 36: Bisphosphonates Update by Alison Dougal](https://reader034.vdocument.in/reader034/viewer/2022050920/549cf322ac7959a62a8b4804/html5/thumbnails/36.jpg)
Pain and sinus LR6• Elective extraction
– IV bisphosphonates lower risk for first 3-6 months
– Patient finished chemo therapy• Protocol
– Pre-op• Liase with oncologist• FBC• Consent
– Peri-op• Pre-op chlorhexidine rinse• LA with adrenaline• No flap raised • De-coronated tooth sectioned and elevated roots
– Post op• Suturing to avoid trauma to soft tissues, vicryl• No packing (surgicell)• Metronidazole 200mg TDS for 5 days• 250-500mg amoxycilin TDS for up to two months
![Page 37: Bisphosphonates Update by Alison Dougal](https://reader034.vdocument.in/reader034/viewer/2022050920/549cf322ac7959a62a8b4804/html5/thumbnails/37.jpg)
Patient and dentist relieved
• Patient irrigates socket with chlorhexidine BD for two months
• Review– 2 weeks– 1 month– 2 months
• Healed well with no complications
• Anecdotally, lower incidence of BON than expected in patients with few co-factors
![Page 38: Bisphosphonates Update by Alison Dougal](https://reader034.vdocument.in/reader034/viewer/2022050920/549cf322ac7959a62a8b4804/html5/thumbnails/38.jpg)
Grade 3 mobile tooth
2 months post extraction
![Page 39: Bisphosphonates Update by Alison Dougal](https://reader034.vdocument.in/reader034/viewer/2022050920/549cf322ac7959a62a8b4804/html5/thumbnails/39.jpg)
Chlorhexidine BD for three monthsAmoxycillin 250mg for two months
![Page 40: Bisphosphonates Update by Alison Dougal](https://reader034.vdocument.in/reader034/viewer/2022050920/549cf322ac7959a62a8b4804/html5/thumbnails/40.jpg)
Soft Tissue – crown lenthening
![Page 41: Bisphosphonates Update by Alison Dougal](https://reader034.vdocument.in/reader034/viewer/2022050920/549cf322ac7959a62a8b4804/html5/thumbnails/41.jpg)
Bony Sequestrum and Healing
• Non-invasive management
• Metronidazole and amoxycillin
• Chlorhexidine• 2 -3 months healing
time• Patients given syringe
and instructed to clean• Sequestrum tweezered
out in time
![Page 42: Bisphosphonates Update by Alison Dougal](https://reader034.vdocument.in/reader034/viewer/2022050920/549cf322ac7959a62a8b4804/html5/thumbnails/42.jpg)
Endodontics
• Extremely high risk cancer patient
• No symptoms• XLA LR3 unavoidable• Endodontics LR12
– No instrumentation of apex
– Corsodyl post op (rubber dam)
– Decoronating and seal to avoid soft tissue injuries
– +/- Antibiotics– Fingers crossed
![Page 43: Bisphosphonates Update by Alison Dougal](https://reader034.vdocument.in/reader034/viewer/2022050920/549cf322ac7959a62a8b4804/html5/thumbnails/43.jpg)
Difficult Scenarios highlighting problems to medics
• Male aged 52• Swelling LLQ• Multiple Myeloma• Diabetes• Undergoing chemo therapy• IV Bisphosphonate for 18
months• Post-extraction developed
osteochemonecrosis LLQ• Life saving bone marrow
transplant delayed• Oncologists have initiated
dental screening programme and information leaflets for patients
![Page 44: Bisphosphonates Update by Alison Dougal](https://reader034.vdocument.in/reader034/viewer/2022050920/549cf322ac7959a62a8b4804/html5/thumbnails/44.jpg)
Future • Risk of treating patients taking oral
bisphosphonates is small!!• Will this increase in time (long half
life)• Price of dental neglect due to fear is
high• Regular routine and preventive care
essential• Perceived increased need for services
of endodontists• Most cases of BON occur in high risk
patients taking high risk drugs after dental surgery
• Guidelines updated regularly• Comprehensive oral evaluation on
patients starting therapy• New generation of effective drugs
avoiding BON
![Page 45: Bisphosphonates Update by Alison Dougal](https://reader034.vdocument.in/reader034/viewer/2022050920/549cf322ac7959a62a8b4804/html5/thumbnails/45.jpg)
Thank you for listening
Notes available on
ISDH website soon